Imaging in COVID-19: A Review
Keywords:
Coronavirus infection, , pneumonia, COVID-19, extrapulmonary manifestationAbstract
The coronavirus disease 2019 (COVID-19) outbreak, which started in Wuhan, China, has rapidly spread worldwide. It is a
highly infectious viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and diagnosed by
real-time reverse transcription-polymerase chain reaction (RT-PCR) of the viral nucleic acid. COVID-19 usually presents with
symptoms related to respiratory system; however, lately there have been number of reports with extrapulmonary manifestations.
Some patients have shown severe cardiovascular damage, acute-onset hepatitis, acute renal failure, encephalitis and myositis.
Although the role of imaging has been limited in diagnosis, it is becoming more and more central to supplementing diagnosis,
assessing severity, progression and in the follow-up of these patients. This article is aimed to review the role of imaging in
COVID-19.
Downloads
Published
Issue
Section
License
All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that: The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details. If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated. No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.
